In limited studies hyperbaric oxygen therapy (HBOT) has been shown to reduce the pain and tenderness associated
with complex regional pain syndrome (CRPS) and other chronic pain disorders. Physicians may prescribe HBOT as an adjunct
or alternative to drug treatments and other therapies.
Although there have been controlled, double-blinded studies of treatment of complex regional pain syndrome with
hyperbaric oxygen, much of this research was conducted outside the United States or was limited to animal models.
As of July 2015 there are no studies of CRPS and HBOT registed on ClinicalTrials.gov.
[ ClinicalTrails.gov ]
With such limited supporting data and no future research planned, we rate the amount of available supporting evidence for the effective treatment of CRPS
with HBOT as scant.
Those seeking treatment for chronic regional pain syndrome should beware of practitioners making bold claims for hyperbaric oxygen therapy.
Advertising a specific medical benefit from a treatment that has not been approved by the US Food and Drug Administration for
that purpose is a violation of US federal law. Never pay to participate in a clinical trial.